FutureFuel Announces Third Quarter 2026 Results
Key Highlights
- ➤Q3 revenue $104.7 million, up $82.0 million year over year
- ➤Q3 GAAP net loss $8.4 million, or $0.19 per diluted share
- ➤Q4 Adjusted EBITDA expected at approximately $7 million
- ➤Full-year 2026 Adjusted EBITDA expected to turn positive
- ➤Biofuels utilization rose to 83% from 56% in Q2 2026
Expert Statements
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
“Third quarter results reflected strong biodiesel demand and improved production economics, offset by extended maintenance on two dedicated chemicals production units that weighed on volumes, operating leverage and profitability in the period,”
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
“Chemicals production has since returned to normalized rates, biodiesel demand remains robust, and production economics remain favorable, positioning us for a solid finish to 2026.”
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
“Demand conditions have further strengthened into the fourth quarter versus third quarter levels. We currently expect fourth quarter Adjusted EBITDA of approximately $7 million, positioning us to deliver positive Adjusted EBITDA for the full-year 2026. Importantly, we do not anticipate major planned maintenance at Batesville through the first quarter of 2027.”
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
“FutureFuel remains a platform for growth, one whose fully domestic manufacturing footprint, deep specialty-chemicals expertise, capital-efficient approach to growth and longstanding partnerships with world-class customers provide a strong foundation as we move into this next chapter of value creation.”
BATESVILLE, Ark., Nov. 09, 2026 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the third quarter and nine months ended September 30, 2026.
THIRD QUARTER 2026 RESULTS (As compared to third quarter 2025) * Total Revenues of $104.7 million, increase of $82.0 million * GAAP Net Loss of ($8.4) million, or ($0.19) per diluted share, increase of $0.8 million and $0.02 per share * Adjusted EBITDA of ($4.9) million(()(1)), increase of $0.4 million * Anticipate positive Adjusted EBITDA in the fourth quarter and in the full-year 2026((2)) (1) A non-GAAP financial measure. See “Non-GAAP Financial Measures” for a description of the measure and a reconciliation to the applicable GAAP measure. (2 ) A non-GAAP financial measure. No reconciliation for full-year 2026 Adjusted EBITDA is included herein because we are unable to quantify certain amounts that would be required to be included in such reconciliation without unreasonable efforts due to the high variability and difficulty to predict certain items excluded from Adjusted EBITDA.
Get started
Create a free account to read the full story.